TaiMed Biologics (ROCO:4147) Other Long-Term Liabilities : NT$299.8 Mil (As of Mar. 2025)

View and export this data going back to 2010. Start your Free Trial

What is TaiMed Biologics Other Long-Term Liabilities?

TaiMed Biologics's other long-term liabilities for the quarter that ended in Mar. 2025 was NT$299.8 Mil.

TaiMed Biologics's quarterly other long-term liabilities declined from Sep. 2024 (NT$363.8 Mil) to Dec. 2024 (NT$348.5 Mil) and declined from Dec. 2024 (NT$348.5 Mil) to Mar. 2025 (NT$299.8 Mil).

TaiMed Biologics's annual other long-term liabilities declined from Dec. 2022 (NT$506.5 Mil) to Dec. 2023 (NT$445.0 Mil) and declined from Dec. 2023 (NT$445.0 Mil) to Dec. 2024 (NT$348.5 Mil).

TaiMed Biologics Other Long-Term Liabilities Historical Data

The historical data trend for TaiMed Biologics's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TaiMed Biologics Other Long-Term Liabilities Chart

TaiMed Biologics Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Long-Term Liabilities

Get a 7-Day Free Trial

751.60

878.77

506.52

444.96

348.45

TaiMed Biologics Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Long-Term Liabilities	Get a 7-Day Free Trial															434.27	402.81	363.84	348.45	299.79

TaiMed Biologics Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

TaiMed Biologics Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of TaiMed Biologics's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

TaiMed Biologics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TaiMed Biologics Inc (ROCO:4147) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 607, Ruiguang Road, 3rd Floor, Neihu District, Taipei, TWN, 11492

Website

https://www.taimedbiologics.com

TaiMed Biologics Inc is a biotechnology company committed to have the expertise and capability in developing, manufacturing and commercializing new drugs for the treatment and prevention of infectious diseases. Its products include Trogarzo IV Infusion, Trogarzo IV Push, TMB-365, TMB-365/TMB-380 (TMB-365 and TMB-380 combination), and Antibody-Drug Conjugates, ADCs.

TaiMed Biologics Headlines

No Headlines